The global digital therapeutics market is on track to achieve a valuation of USD 4.8 billion in 2022. With a remarkable compound annual growth rate (CAGR) of 24.4% projected for the forecast period, the market is anticipated to surge to USD 42.5 billion by 2032.
This exceptional growth reflects the increasing adoption of digital health solutions and the rising demand for innovative, technology-driven treatment options. Digital therapeutics are revolutionizing patient care by providing effective, accessible, and personalized therapeutic solutions, thereby driving the significant expansion of the market.
The accelerated growth in the digital therapeutics sector highlights the increasing adoption of technology-driven healthcare solutions. As digital health tools and apps become more integral to patient care and chronic disease management, the market is rapidly evolving to meet rising demand.
Digital therapeutics offer innovative treatment solutions through software-based interventions, making healthcare more accessible and personalized. This surge in market value underscores the growing recognition of digital therapeutics as a crucial component in the future of healthcare.
At the heart of this transformative journey is the exploration of patient data, obtained through digital therapeutic products, by key industry players. These pioneers are actively deciphering how this wealth of information can inform coverage decisions and contribute to more informed healthcare choices. The intersection of technology and healthcare is proving to be a fertile ground for innovation, with startups vying for investor attention with groundbreaking digital therapeutic concepts.
Manufacturers are combining off-patent compounds with medical devices farther up the innovation spectrum, such as altering the mode of administration with better inhalers and auto-injectors. This necessitates a bigger investment in research and development, as well as greater usage of collaboration between molecule producers and device manufacturers.
Mass-market platforms present a significant possibility for interaction at scale. Manufacturers of consumer gadgets, namely smartphones and smartwatches, have included healthcare services and encouraged third-party developers to create apps for better patient outcomes.
Simultaneously, attempts have been made to improve the quality of available apps, with major app shops enforcing certain quality criteria. This is a beneficial development because it is critical to place a premium on the secure storage of research-grade data. Owing to the above-mentioned factors, the Global Digital Therapeutics Industry will expand at a considerable pace over the assessment period.
“Increasing awareness regarding digital therapeutics across emerging economies, along with growing adoption of healthcare wearables will continue driving growth in the market over the forecast period,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Digital Therapeutics Market Key Takeaways:
- Combination therapy as a solution is expected to account for an approximate market share value of 4% of the global market in 2022.
- By application, management is expected to hold a dominant market share value of 1% in the 2022 global market.
- Central nervous system disorders by indication displayed a CAGR growth value expected to reach 2% by 2032.
- Direct-to-patients/consumers are a dominant segment in terms of the business model within the global market, carrying an estimated market share value of about 8% in 2022.
- The U.S. accounted for 3% of the North American digital therapeutics market in 2021.
Digital Therapeutics Market Key Players:
- Teladoc Health, Inc.
- Click Therapeutics, Inc.
- Welldoc
- HYGIEIA
- DarioHealth Corp
- BigHealth
- Orexo AB
- Akili Interactive Labs, Inc.
- Freespira
- Voluntis
- Kaia Health
- Kaiku Health
- Theranica Bio-Electronics Ltd.
- Propeller Health
- Orexo US, Inc.
- TALi Digital Limited
- Limbix Health, Inc.
Digital Therapeutics Market Competition
Digital therapies are a lucrative investment field due to a developing market environment, venture capital funding, and digital acceleration in response to the COVID-19 pandemic. The market is a fragmented space with heavy competition. Digital therapeutics can become an effective and economical solution for diseases and conditions that affect a large number of people. DTx software products have attracted a huge number of investors because of their lower development costs, simplicity of distribution, and ability to scale up their applications.
For instance:
- In January 2021, the FDA approved Theranica’s Nerivio® for an expanded indication for acute treatment of episodic or chronic migraine in adolescents.
- Limbix Therapeutics Inc. in October 2021 launched “SparkRx”, the first evidence-based digital therapeutic for adolescents with symptoms of depression.
A Old Full Report Analysis Click Here
Key Segments Covered in Digital Therapeutics Market Research
By Solution:
- Monotherapy
- Combination Therapy
By Application:
- Prevention
- Management
- Treatment
By Indication:
- Diabetes
- Obesity
- Gastrointestinal Disorders
- Cardiovascular Disease
- Central Nervous Systems
- Others
By Business Model:
- Direct to consumer
- Fee-for-service
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube